Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $987.52 | 28 | 98.5% |
| Education | $14.85 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $347.77 | 7 | $0 (2023) |
| Braeburn Inc. | $237.80 | 7 | $0 (2024) |
| Alkermes, Inc. | $175.58 | 4 | $0 (2024) |
| ABBVIE INC. | $142.77 | 6 | $0 (2024) |
| Indivior Inc. | $98.45 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $394.90 | 14 | Braeburn Inc. ($213.53) |
| 2023 | $440.60 | 11 | Gilead Sciences, Inc. ($303.39) |
| 2022 | $166.87 | 4 | Alkermes, Inc. ($106.12) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: OUD | ||||||
| 11/06/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: Opioid Use Disorder | ||||||
| 10/29/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: VIROLOGY | ||||||
| 09/17/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: OUD | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Opioid Use Disorder | ||||||
| 06/26/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Opioid Use Disorder | ||||||
| 06/12/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: OUD | ||||||
| 06/11/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | Cash or cash equivalent | $96.58 | General |
| Category: Opioid Use Disorder | ||||||
| 05/08/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: Opioid Use Disorder | ||||||
| 02/28/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: CNS | ||||||
| 02/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.25 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: OUD | ||||||
| 01/11/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Opioid Use Disorder | ||||||
| 12/07/2023 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Opioid Use Disorder | ||||||
| 10/24/2023 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $110.00 | General |
| Category: HCV | ||||||
| 08/31/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.81 | General |
| 08/26/2023 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: CNS | ||||||
| 05/21/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.87 | General |
| 04/25/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: OUD | ||||||
| 04/17/2023 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: HCV | ||||||
| 03/31/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: VIROLOGY | ||||||
| 02/20/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $32.75 | General |
| Category: VIROLOGY | ||||||
| 01/20/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.72 | General |
| 01/13/2023 | Alkermes, Inc. | Vivitrol (Drug) | Education | In-kind items and services | $14.85 | General |
| Category: CNS | ||||||
About Stuart Ross
Stuart Ross is a Addiction Medicine healthcare provider based in Cookeville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2017. The National Provider Identifier (NPI) number assigned to this provider is 1215457445.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stuart Ross has received a total of $1,002 in payments from pharmaceutical and medical device companies, with $394.90 received in 2024. These payments were reported across 29 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($987.52).
Practice Information
- Specialty Addiction Medicine
- Location Cookeville, TN
- Active Since 06/20/2017
- Last Updated 10/14/2024
- Taxonomy Code 207QA0401X
- Entity Type Individual
- NPI Number 1215457445
Products in Payments
- BRIXADI (Drug) $237.80
- Epclusa (Drug) $234.99
- VIVITROL (Drug) $131.75
- SUBLOCADE (Drug) $98.45
- MAVYRET (Drug) $86.74
- VRAYLAR (Drug) $56.03
- Vivitrol (Drug) $43.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.